Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Cesaro, S; Verheggen, I; Tridello, G; Styczynski, J; Roeven, WHM; Hwang, A; Stamouli, M; Petrov, Y; Ben Abdeljelil, N; Mazilier, P; Zaidman, I; Tambaro, FP; Elias, S; Verna, M; Ricoma, JM; Karas, M; Corral, LL; Goussetis, E; Cerretti, R; Perruccio, K; Hornakova, M; Wölfl, M; Nordlander, A; Biffi, A; Spadea, M; Salinas, AS; Bramanti, S; Belendez, C; Skert, C; Gozdzik, J; Cuoghi, A; Mas, MH; Pennisi, M; de Becker, A; Richardson, D; Peric, Z; de la Camara, R; Averbuch, D.

A survey on the practices and the management of hemorrhagic cystitis in patients who undergo allogeneic hematopoietic stem cell transplantation, on behalf of the Infectious Diseases Working Party of EBMT

BONE MARROW TRANSPLANTATION. 2025; : Nº de citas: 1 [doi:10.1038/s41409-025-02703-1]

Capes, A; Mooyaart, JE; Blaise, D; Bramanti, S; Kwon, M; Mohty, M; Chevallier, P; Vydra, J; Reményi, P; Forcade, E; Corral, LL; Itälä-Remes, M; Bazarbachi, A; Derenzini, E; Hoogenboom, JD; Kuball, J; Battipaglia, G; Malard, F; Ruggeri, A.

Impact of the addition of antithymocyte globulin to post-transplantation cyclophosphamide in haploidentical transplantation with peripheral blood compared to post-transplantation cyclophosphamide alone: A retrospective study on behalf of the Cellular Therapy and Immunobiology Working Party of the European Society for Blood and Marrow Transplantation

BRITISH JOURNAL OF HAEMATOLOGY. 2025; : Nº de citas: 2 [doi:10.1111/bjh.70050]

Chorafa, E; Iosifidis, E; Oletto, A; Warris, A; Castagnola, E; Bruggemann, R; Groll, AH; Lehrnbecher, T; Antolin, LF; Mesini, A; Alkhaaldi, AA; Baquero-Artigao, F; Cetin, BS; Ebrahimi-Fakhari, D; Emonts, M; Esposito, S; Fainardi, V; Ghimenton-Walters, E; Gijón, M; Guerrero, AG; Grasa, CD; Kairiene, I; Kildonaviciute, K; Kourti, M; Manzanares, A; Mendoza-Palomar, N; Noni, M; Papakonstantinou, E; Paulus, S; Perwein, T; Rascon, J; Rincón-López, E; Soler-Palacin, P; Solopova, G; Spoulou, V; Strenger, V; Tedford, K; Tzika, C; Zsigmond, B; Roilides, E.

Antifungal Use in Immunocompromised Children in Europe: A 12-Week Multicenter Weekly Point Prevalence Survey (CALYPSO)

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2025; 47(6): 222-230 Nº de citas: 2 [doi:10.1097/MPH.0000000000003070]

Carpio, C; de la Cruz-Vicente, F; García-Sanz, R; Zeberio, I; Barrenetxea, C; Domingo-Domenech, E; Bastos, M; Martinez, AR; Gómez-Prieto, P; Rodriguez, A; Casanova, M; Cladera-Serra, A; Cespedes, JN; Martínez, C; Moreno-Velázquez, M; Garcia-Galea, E; Abrisqueta, P; Bosch, F.

A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial

BRITISH JOURNAL OF HAEMATOLOGY. 2025; : Nº de citas: 2 [doi:10.1111/bjh.70028]

Gomez-Llobell, M; Smith, CS; Gómez-Costas, D; Gómez-Centurión, I; Domínguez, JMG; Escudero-Vilaplana, V; Bullido, YF; Carbonell, D; Pion, M; Bailén, R; Gil-Perotin, S; Ginés, MLM; Revuelta-Herrero, JL; Fernández-Caldas, P; Fernández, VAP; Collado-Borrell, R; Bastos-Oreiro, M; Villanueva-Bueno, C; García-Sanz, R; Kwon, M.

ICANS risk model in CD19 CAR-T therapy: insights from serum and CSF cytokine profiling

BONE MARROW TRANSPLANTATION. 2025; : Nº de citas: 8 [doi:10.1038/s41409-025-02679-y]

Marin-Quílez, A; Sánchez-Fuentes, A; Zamora-Cánovas, A; Gómez-González, PL; Diaz-Ajenjo, L; Benito, R; Rodríguez-Alén, A; Sevivas, T; Murciano, T; Murillo, L; Butta, NV; Revilla, N; Campos, R; Escribano, P; Esteve, J; Fernández-Mosteirin, N; Ferrer-Marin, F; Hernández, L; Huerta-Aragonés, J; León, A; López-Duarte, M; López, E; Martín-Salces, M; Nomdedeu, M; Oña, R; Peláez-Pleguezuelos, I; Ramos, F; Sebastián, E; Serrano, C; Sierra-Aisa, C; Vidal-Laso, R; González-Porras, JR; Lozano, ML; Bastida, JM; Rivera, J.

Insights into the clinical, platelet and genetic landscape of inherited thrombocytopenia with malignancy risk

BRITISH JOURNAL OF HAEMATOLOGY. 2025; : Nº de citas: 5 [doi:10.1111/bjh.70001]

Monje Fuente S; Del Cañizo López A; Ordóñez Pereira J; García-Casillas MA; Pérez Egido L; Bada Bosch I; Bueno Romero J; Cerdá Berrocal J; De La Torre Macías M; Cela De Julián E; González San Segundo C; de Agustín Asensio JC.

Intraoperative radiotherapy in the local control of chest wall Ewing sarcoma.

Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica. 2025; 38(3): 100-105 [doi:10.54847/cp.2025.03.13]

Bento, L; Gutiérrez, A; Martinez, C; Verdet, MCO; Sorribes, M; Caballero, AC; Peña, M; Pérez, A; Jiménez-Ubieto, A; Medina, L; Bastos-Oreiro, M; Caldas-González, PF; Navarro, B; Salcedo, I; Abrisqueta, P; Español, I; Cornago, J; Martín-Moro, F; García, L; Gómez, P; Varela, MR; Puente, M; Zanabili, J; Zudaire, T; Zeberio, I; del Campo, R; González, L; González, P; Blázquez, C; Rovira, J; Sitges, M; Franch-Sarto, M; Cabero, A; Mussetti, A; Montoro, J; Sampol, A; Sureda, A; Caballero, D; García-Sancho, AM.

Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study

Blood Advances. 2025; 9(13): 3281-3292 Nº de citas: 2 [doi:10.1182/bloodadvances.2024015415]

Pena-Burgos, EM; Duart, MA; Lotto, FA; Bravo-Arribas, C; Martínez-Payo, C; De León-Luis, JA; Suárez-González, J; Pozo-Kreilinger, JJ; Regojo-Zapata, RM.

Intrauterine-diagnosed fetal intracranial adamantinomatous craniopharyngioma: A case report with histopathological and molecular characterization

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. 2025; : [doi:10.1002/ijgo.70357]

Verdú-Bou, M; Baptista, MJ; Ribeiro, ML; Méndez-López, A; Profitós-Pelejà, N; Frontzek, F; Roué, G; Mate, JL; Pellicer, M; Abrisqueta, P; Castellví, J; Bastos-Oreiro, M; Menárguez, J; Alcoceba, M; González-Barca, E; Climent, F; Salar, A; Sancho, JM; Staiger, AM; Ott, G; Anagnostopoulos, I; Esteller, M; Lenz, G; Tapia, G; Navarro, JT.

The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

Blood Advances. 2025; 9(12): 2953-2967 Nº de citas: 3 [doi:10.1182/bloodadvances.2025016180]

Kuter, DJ; Ghanima, W; Cooper, N; Liebman, HA; Zhang, L; Hu, Y; Miyakawa, Y; Homenda, W; Galindo, LEM; Basquiera, AL; Tan, CW; Saydam, G; Huetter-Kroenke, ML; Chai-Adisaksopha, C; Gomez-Almaguer, D; Tran, H; Shin, HJ; Junior, ADD; Lazar, Z; Izquierdo, CP; Kirgner, I; Lucchini, E; Kuzmina, G; Fillitz, M; Audia, S; Taparia, M; Cordoba, M; Diab, R; Yao, MJ; Gouia, I; Lee, MCL; Daak, A.

Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study

BLOOD. 2025; 145(24): 2914-2926 Nº de citas: 40 [doi:10.1182/blood.2024027336]

Bergas, A; de Egea, G; Albasanz-Puig, A; Machado, M; Vinñdo, B; Estévez-Prieto, A; Maluquer, C; Carro, I; Pérez-González, A; Regalado-Artamendi, I; Gómez-Centurión, IA; Laporte-Amargós, J; Sastre-Escolà, E; Badia-Tejero, AM; García, P; Larrosa, N; Muñoz, P; Berbel, D; Ardanuy, C; Carratala, J; Gudiol, C.

Effectiveness of the BioFire FilmArray for the rapid detection of bloodstream infection in haematological patients with febrile neutropenia (the ONFIRE study): study protocol of a prospective, multicentre observational study at three reference university hospitals in Spain

BMJ Open. 2025; 15(6): Nº de citas: 2 [doi:10.1136/bmjopen-2025-101040]

Westin, J; Phillips, TJ; Mehta, A; Hoffmann, MS; Gonzalez-Barca, E; Thieblemont, C; Bastos-Oreiro, M; Greil, R; Giebel, S; Wei, MC; Wang, J; Bucher, R; Sit, J; Penuel, E; Purev, E; Yee, DL; Bergua-Burgues, JM.

Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study

Blood Advances. 2025; 9(10): 2461-2472 Nº de citas: 9 [doi:10.1182/bloodadvances.2024014907]

Montoro, J; Eikema, DJ; Piepenbroek, B; Tuffnell, J; Halahleh, K; Kulagin, A; Alahmari, A; Aksoy, BA; Remenyi, P; Itaela-Remes, M; Gulbas, Z; Mcdonald, A; Apte, S; Kwon, M; Rovira, M; Kharya, G; Potter, V; Gambella, M; Schroeder, T; Giammarco, S; Bazarbachi, A; Aljurf, M; Ho, ALY; Dalle, JH; Vydra, J; Sanz, J; Perez-Simon, JA; Colita, A; Collin, M; Tanase, A; Halkes, C; Kulasekararaj, A; Risitano, A; de Latour, RP.

Donor impact on allogeneic transplant outcomes with PTCy for severe aplastic anemia: a study of the SAAWP EBMT

BONE MARROW TRANSPLANTATION. 2025; 60(8): 1152-1159 Nº de citas: 3 [doi:10.1038/s41409-025-02633-y]

Battipaglia, G; Labopin, M; Kulagin, A; Versluis, J; Choi, G; Meijer, E; Rovira, M; van Gorkom, G; Kwon, M; Koc, Y; Vydra, J; Chiusolo, P; Patel, A; Piemontese, S; Sanz, J; Ruggeri, A; Nagler, A; Ciceri, F; Mohty, M.

Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT

BONE MARROW TRANSPLANTATION. 2025; : [doi:10.1038/s41409-025-02610-5]

González-Gil, C; Lopes, T; Morgades, M; Fuster-Tormo, F; Montesinos, P; Medina, CR; Hermosin, L; González-Martínez, T; Queipo, MP; González-Campos, J; Martínez-Sánchez, P; Díaz-Beya, M; Coll, R; Maluquer, C; Zamora, L; Artola, T; Vall-Llovera, F; Tormo, M; Torrent, A; Martínez-Laperche, C; Gil-Cortés, C; Barba, P; Cervera, M; Ribera, J; Fernández-Delgado, M; Ayala, R; Cladera, A; Mateos, MC; Vidal, MJ; Feliu, J; Torres, A; Azaceta, G; Calasanz, MJ; Bigas, A; Esteller, M; Orfao, A; Ribera, JM; Genescà, E.

Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials

HemaSphere. 2025; 9(5): Nº de citas: 1 [doi:10.1002/hem3.70148]

Puyo, PV; Christou, S; Campisi, S; Rodriguez-Sánchez, MA; Reidel, S; Perez-Hoyo, S; Mota, M; Savvidou, I; Rekleiti, A; Salvo, A; Voi, V; Ferrero, GB; Mandrile, G; Gaglioti, CM; Cela, E; Ponce-Salas, B; Bardón-Cancho, EJ; Flevari, P; Voskaridou-Dimoula, E; Nur, E; Biemond, BJ; Delaporta, P; Beneitez-Pastor, D; Gimbert, AC; Spasiano, A; Besse-Hammer, T; Lafiatis, IG; Dedeken, L; Raso, S; Ruiz-Llobet, A; Bagnato, S; Labarque, V; Glenthoj, A; Ruffo, GB; Guerzoni, ME; Hafraoui, K; Pistoia, L; Rosso, R; Tagliaferri, L; Gonzalez-Urdiales, P; Benghiat, FS; de Montalembert, M; Teles, MJ; Vanderfaeillie, A; Bertoni, E; Cuzzubbo, D; Ferreira, T; Saunders, CJ; Stiakaki, E; van de Velde, AL; Diamantidis, MD; Kerkhoffs, JLH; Oliveira, MI; Quota, A; Russo, R; Van Damme, A; Marina, MA; Reggiori, ML; Rijneveld, AW; Gallego, AR; Colombatti, R; Iolascon, A; Taher, A; Gulbis, B; Roy, NBA; Mañú-Pereira, MD.

COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet

Orphanet Journal of Rare Diseases. 2025; 20(1): Nº de citas: 1 [doi:10.1186/s13023-025-03683-7]

Encinas, C; Lozano, V; Hlavacek, P; Llinares, J; Toribio-Castelló, S; Carcedo, D; Asis-Montalt, J; Martínez-López, J.

Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain

Oncology and Therapy. 2025; 13(2): 381-395 Nº de citas: 4 [doi:10.1007/s40487-025-00333-7]